{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:24:46Z","timestamp":1784204686606,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK060990"],"award-info":[{"award-number":["U01DK060990"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK060984"],"award-info":[{"award-number":["U01DK060984"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK061022"],"award-info":[{"award-number":["U01DK061022"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK061021"],"award-info":[{"award-number":["U01DK061021"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK061028"],"award-info":[{"award-number":["U01DK061028"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK060980"],"award-info":[{"award-number":["U01DK060980"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK060963"],"award-info":[{"award-number":["U01DK060963"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U01DK060902"],"award-info":[{"award-number":["U01DK060902"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08DK106523"],"award-info":[{"award-number":["K08DK106523"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK089503"],"award-info":[{"award-number":["P30DK089503"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK082841"],"award-info":[{"award-number":["DK082841"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK081943"],"award-info":[{"award-number":["P30DK081943"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK020572"],"award-info":[{"award-number":["P30DK020572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK097153"],"award-info":[{"award-number":["DK097153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000433"],"award-info":[{"award-number":["UL1TR000433"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","award":["UL1TR000003"],"award-info":[{"award-number":["UL1TR000003"]}],"id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["UL1 TR-000424"],"award-info":[{"award-number":["UL1 TR-000424"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Clinical Research Center","award":["M01 RR-16500"],"award-info":[{"award-number":["M01 RR-16500"]}]},{"name":"University of Maryland and the Cleveland Clinical and Translational Science Collaborative","award":["UL1TR000439"],"award-info":[{"award-number":["UL1TR000439"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1RR029879"],"award-info":[{"award-number":["UL1RR029879"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010443","name":"University of Illinois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["UL1 RR-024131"],"award-info":[{"award-number":["UL1 RR-024131"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The clinical relevance of arachidonic acid (AA) metabolites in chronic kidney disease (CKD) progression is poorly understood. We aimed to compare the concentrations of 85 enzymatic pathway products of AA metabolism in patients with CKD who progressed to end-stage kidney disease (ESKD) versus patients who did not in a subcohort of Chronic Renal Insufficiency Cohort (CRIC) and to estimate the risk of CKD progression and major cardiovascular events by levels of AA metabolites and their link to enzymatic metabolic pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total 123 patients in the CRIC study who progressed to ESKD were frequency matched with 177 nonprogressors and serum eicosanoids were quantified by mass spectrometry. We applied serum collected at patients\u2019 Year 1 visit and outcome of progression to ESKD was ascertained over the next 10\u2009years. We used logistic regression models for risk estimation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Baseline 15-hydroxyeicosatetraenoate (HETE) and 20-HETE levels were significantly elevated in progressors (false discovery rate Q\u2009\u2264\u20090.026). The median 20-HETE level was 7.6\u2009pmol\/mL [interquartile range (IQR) 4.2\u201314.5] in progressors and 5.4\u2009pmol\/mL (IQR 2.8\u20139.4) in nonprogressors (P\u2009&amp;lt;\u20090.001). In an adjusted model, only 20-HETE independently predicted CKD progression. Each 1 standard deviation increase in 20-HETE was independently associated with 1.45-fold higher odds of progression (95% confidence interval 1.07\u20131.95; P\u2009=\u20090.017). Principal components of lipoxygenase (LOX) and cytochrome P450 (CYP450) pathways were independently associated with CKD progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found higher odds of CKD progression associated with higher 20-HETE, LOX and CYP450 metabolic pathways. These alterations precede CKD progression and may serve as targets for interventions aimed at halting progression.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ndt\/gfy232","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T19:10:21Z","timestamp":1529608221000},"page":"303-312","source":"Crossref","is-referenced-by-count":26,"title":["Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease"],"prefix":"10.1093","volume":"35","author":[{"given":"Farsad","family":"Afshinnia","sequence":"first","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeman","family":"Byun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Wernisch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Tulane University, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hamm","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Tulane University, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar R","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jones Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Illinois, Center of Innovation for Complex Chronic Healthcare, Jesse Brown VAMC, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Texas Health San Antonio, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I","family":"Feldman","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Michailidis","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI, USA"},{"name":"Michigan Regional Comprehensive Metabolomics Resource Core, University of Michigan, Ann Arbor, MI, USA"},{"name":"Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CRIC Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Kusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga S","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"2020073005570020200_gfy232-B1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chroma.2014.07.006","article-title":"Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples","volume":"1359","author":"Wang","year":"2014","journal-title":"J Chromatogr A"},{"key":"2020073005570020200_gfy232-B2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2020073005570020200_gfy232-B3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J Lipid Res"},{"key":"2020073005570020200_gfy232-B4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1096\/fasebj.9.11.7649404","article-title":"Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases","volume":"9","author":"Goetzl","year":"1995","journal-title":"FASEB J"},{"key":"2020073005570020200_gfy232-B5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: the neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"2020073005570020200_gfy232-B6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0889-857X(21)00465-8","article-title":"Eicosanoids in rheumatoid arthritis","volume":"21","author":"Sperling","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"2020073005570020200_gfy232-B7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.66.2.220","article-title":"Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton","volume":"66","author":"Patel","year":"2004","journal-title":"Mol Pharmacol"},{"key":"2020073005570020200_gfy232-B8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/ki.1993.180","article-title":"Hemodynamic role of arachidonate 12- and 5-lipoxygenases in nephrotoxic serum nephritis","volume":"43","author":"Wu","year":"1993","journal-title":"Kidney Int"},{"key":"2020073005570020200_gfy232-B9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1681\/ASN.2004070568","article-title":"Novel interactions between TGF-\u03b21 actions and the 12\/15-lipoxygenase pathway in mesangial cells","volume":"16","author":"Kim","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/ijms17050684","article-title":"12-Lipoxygenase inhibition on microalbuminuria in type-1 and type-2 diabetes is associated with changes of glomerular angiotensin II type 1 receptor related to insulin resistance","volume":"17","author":"Xu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2020073005570020200_gfy232-B11","doi-asserted-by":"crossref","first-page":"e82482","DOI":"10.1371\/journal.pone.0082482","article-title":"20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS One"},{"key":"2020073005570020200_gfy232-B12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"26","author":"Gangadhariah","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.113.203844","article-title":"20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries","volume":"346","author":"Orozco","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"2020073005570020200_gfy232-B14","doi-asserted-by":"crossref","first-page":"H1359","DOI":"10.1152\/ajpheart.00802.2014","article-title":"20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis","volume":"308","author":"Wang","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020073005570020200_gfy232-B15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","article-title":"Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort","volume":"1","author":"Afshinnia","year":"2016","journal-title":"Kidney Int Rep"},{"key":"2020073005570020200_gfy232-B16","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The chronic renal insufficiency cohort (CRIC) study: design and methods","volume":"14(7 Suppl 2)","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2020073005570020200_gfy232-B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","article-title":"Functional and pathological roles of the 12- and 15-lipoxygenases","volume":"50","author":"Dobrian","year":"2011","journal-title":"Prog Lipid Res"},{"key":"2020073005570020200_gfy232-B20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MNH.0000000000000088","article-title":"Cytochrome P450 eicosanoids in hypertension and renal disease","volume":"24","author":"Fan","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2020073005570020200_gfy232-B21","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of cytochrome P450 metabolites of arachidonic acid in nephrology","volume":"28","author":"Fan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.45.120403.100045","article-title":"Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation","volume":"45","author":"Kroetz","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2020073005570020200_gfy232-B23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"key":"2020073005570020200_gfy232-B24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1194\/jlr.P042176","article-title":"Bioactive lipid mediators in polycystic kidney disease","volume":"55","author":"Klawitter","year":"2014","journal-title":"J Lipid Res"},{"key":"2020073005570020200_gfy232-B25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1194\/jlr.D081414","article-title":"Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI\/HRMS","volume":"59","author":"Mazaleuskaya","year":"2018","journal-title":"J Lipid Res"},{"key":"2020073005570020200_gfy232-B26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2014.08.002","article-title":"Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease","volume":"113-115","author":"Dreisbach","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2020073005570020200_gfy232-B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.06.006","article-title":"The role of 20-HETE in androgen-mediated hypertension","volume":"96","author":"Wu","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2020073005570020200_gfy232-B28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI119279","article-title":"20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+, K+-ATPase","volume":"99","author":"Nowicki","year":"1997","journal-title":"J Clin Invest"},{"key":"2020073005570020200_gfy232-B29","doi-asserted-by":"crossref","first-page":"R2400","DOI":"10.1152\/ajpregu.00791.2006","article-title":"Effects of 20-HETE on Na+ transport and Na+-K+-ATPase activity in the thick ascending loop of Henle","volume":"292","author":"Yu","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020073005570020200_gfy232-B30","first-page":"R579","article-title":"Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats","volume":"267(2 Pt 2)","author":"Ma","year":"1994","journal-title":"Am J Physiol"},{"key":"2020073005570020200_gfy232-B31","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1097\/HJH.0000000000000678","article-title":"20-Hydroxyeicosatetraenoic acid, a far-reaching autacoid in chronic kidney disease: hypertension and beyond","volume":"33","author":"Zoccali","year":"2015","journal-title":"J Hypertens"},{"key":"2020073005570020200_gfy232-B32","doi-asserted-by":"crossref","first-page":"H1018","DOI":"10.1152\/ajpheart.01172.2007","article-title":"20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling","volume":"294","author":"Cheng","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020073005570020200_gfy232-B33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.109.159863","article-title":"20-Hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via I\u03baB kinase-dependent endothelial nitric-oxide synthase uncoupling","volume":"332","author":"Cheng","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2020073005570020200_gfy232-B34","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"key":"2020073005570020200_gfy232-B35","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.90613.2008","article-title":"Glomerular 20-HETE, EETs, and TGF-\u03b21 in diabetic nephropathy","volume":"296","author":"Luo","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020073005570020200_gfy232-B36","first-page":"S101","article-title":"15-Lipoxygenase products as leukotriene antagonists: therapeutic potential in glomerulonephritis","volume":"38","author":"Badr","year":"1992","journal-title":"Kidney Int Suppl"},{"key":"2020073005570020200_gfy232-B37","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1073\/pnas.87.16.6248","article-title":"Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids","volume":"87","author":"Brezinski","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020073005570020200_gfy232-B38","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ki.1992.176","article-title":"Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat","volume":"41","author":"Fischer","year":"1992","journal-title":"Kidney Int"},{"key":"2020073005570020200_gfy232-B39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ki.1994.131","article-title":"15-HETE: selective incorporation into inositol phospholipids of MDCK cells","volume":"45","author":"Girton","year":"1994","journal-title":"Kidney Int"},{"key":"2020073005570020200_gfy232-B40","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/HJH.0000000000000621","article-title":"n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease","volume":"33","author":"Barden","year":"2015","journal-title":"J Hypertens"},{"key":"2020073005570020200_gfy232-B41","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1476-5381.2011.01321.x","article-title":"A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm","volume":"163","author":"Revermann","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2020073005570020200_gfy232-B42","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1046\/j.1523-1755.63.s84.26.x","article-title":"5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients","volume":"63","author":"Maccarrone","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"2020073005570020200_gfy232-B43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3858\/emm.2011.43.2.012","article-title":"Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK","volume":"43","author":"Ha","year":"2011","journal-title":"Exp Mol Med"},{"key":"2020073005570020200_gfy232-B44","article-title":"Inhibition of 12\/15-lipoxygenase reduces renal inflammation and injury in streptozotocin-induced diabetic mice","volume":"6","author":"Faulkner","year":"2015","journal-title":"J Diabetes Metab"},{"key":"2020073005570020200_gfy232-B45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.plefa.2004.06.004","article-title":"12\/15-Lipoxygenase inhibitors in diabetic nephropathy in the rat","volume":"72","author":"Ma","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2020073005570020200_gfy232-B46","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1046\/j.1523-1755.2001.0590041354.x","article-title":"12-Lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy","volume":"59","author":"Kang","year":"2001","journal-title":"Kidney Int"},{"key":"2020073005570020200_gfy232-B47","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1097\/01.ASN.0000099702.16315.DE","article-title":"Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen \u03b15(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes","volume":"14","author":"Kang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020073005570020200_gfy232-B48","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1046\/j.1523-1755.2003.00286.x","article-title":"Differential behavior of mesangial cells derived from 12\/15-lipoxygenase knockout mice relative to control mice","volume":"64","author":"Kim","year":"2003","journal-title":"Kidney Int"},{"key":"2020073005570020200_gfy232-B49","doi-asserted-by":"crossref","first-page":"F985","DOI":"10.1152\/ajprenal.00181.2002","article-title":"Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells","volume":"283","author":"Reddy","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020073005570020200_gfy232-B50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.107.104463","article-title":"A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure","volume":"51","author":"Ward","year":"2008","journal-title":"Hypertension"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/2\/303\/33548930\/gfy232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/2\/303\/33548930\/gfy232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T03:58:31Z","timestamp":1661486311000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/35\/2\/303\/5059540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,7,25]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy232","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2018,7,25]]}}}